Celgene taps Cypher Genomics for cancer R&D; Aura snags orphan tag;

@FierceBiotech: Regeneron's arthritis drug aces Phase III with the FDA in sight. News | Follow @FierceBiotech

@JohnCFierce: What's your list of top 5 public biotechs? (Potential, management, smart execution) I'd put $BLUE in that group. Any other suggestions? | Follow @JohnCFierce

> Celgene ($CELG) has reached out to Cypher Genomics to collaborate on determining the ideal patients for clinical trials in oncology. News

> Aura Biosciences picked up the FDA's orphan drug designation for its in-development treatment for uveal melanoma. More

Medical Device News

@FierceMedDev: ICYMI yesterday: MD Anderson Cancer Center partners to start breast cancer pilot project using Apple Watch. Report | Follow @FierceMedDev

@VarunSaxena2: St. Jude says alternative imaging system is optimal during stenting procedures. Story | Follow @VarunSaxena2

@EmilyWFierce: San Francisco startup reels in $30M for disease outbreak prediction tech. More  | Follow @EmilyWFierce

> Philips collaborates with Dutch hospital to develop diabetic foot disease Dx. More

> Issue that led to halt of St. Jude TAVR trial no cause for concern, EuroPCR experts say. News

Pharma News

@FiercePharma:  NIH steps in with $9M Vanderbilt grant after rough season for flu vaccines. More | Follow @FiercePharma

@EricPFierce: ICYMI: #FDA blesses Baxter #saline plant in Spain for shipments to U.S. of  0.9% sodium chloride. Article | Follow @EricPFierce

@CarlyHFierce: Novo, Baxter spar over hemophilia patent amid ITC probe. Story | Follow @CarlyHFierce

> Report: Cadila next in line for injectables bulk-up as it nears deal for Claris. More

> Aspen unloads $301M worth of meds to fuel expansion abroad. News

Vaccines News

> Canadian biotech Medicago building $200M vaccine plant. Item

> Genocea's genital herpes vaccine succeeds in Ph II. More

> Takeda, Daiichi Sankyo ink flu vaccine distribution pacts with Japan's Kaketsuken. Story

> Zydus Cadila preps for big splash into India's vaccines market. Article

> U.K.'s PsiOxus scores $39M for colorectal cancer vaccine combo trial. Report

CRO News

> Quintiles' founders bank $770M in secondary offering. Item

> InVentiv invests in compliance as regulations shift for real-world studies. Story

> Quotient Clinical soars in its first year after a PE buyout. Report

> WuXi posts another big quarter as it faces a big decision. Article

Pharma Manufacturing News

> Hospira recalls solution marked as heparin. Item

> Zydus Cadila said to be buying Claris' sterile injectables biz as landscape morphs. Story

> Apotex recalling generic Zyprexa because the antipsychotic may be too weak. News

> Fund grows to $200M for victims of meningitis outbreak tied to compounder. Article

> Medicago building $200M plant to manufacture vaccines from plants. Report

Pharma Asia News

> Sinocare said to bid $1B for Bayer diabetes devices, piping Panasonic. More

> China academy plans clinical trials on artemisinin derivative aimed at lupus. News

> Japan eyes higher target for generics despite missing earlier aims. Article

> Gilead's Sovaldi faces renewed advocacy CL pressure, this time for China and Russia. Story

> Glenmark gets India nod on shares sales to foreign investors, Temasek in. Report

Suggested Articles

Cancer biotech Zentalis Pharmaceuticals priced its IPO at $165 million, eclipsing the $100 million goal it laid out in early March.

The agreement gives Innovax access to a GSK adjuvant to enhance the immune response triggered by its recombinant protein-based vaccine.

Johnson & Johnson is paying Fate Therapeutics $50 million upfront to collaborate on up to four CAR NK and CAR-T cell therapies.